De-Risking Immunotherapy Targets with Next-Gen HLA Discovery Platforms
Dr. Rico Buchli and the HLA Protein Technologies team provide answers to questions from their webinar on next-generation soluble HLA peptide discovery platforms to strengthen early immunotherapy R&D.
De-Risking Immunotherapy Targets with Next-Gen HLA Discovery Platforms
In this webinar, Rico Buchli, PhD, shares how next-generation soluble HLA peptide discovery platforms can strengthen early immunotherapy R&D - from target identification and confirmation to receptor/drug validation and translational decision-making.
CRISPR Gene Editing in Primary T Cells: A Case Study in the Fight Against HIV
Get practical insight into CRISPR-Cas9 gene editing in primary immune cells and how it can be applied to study drug action in a physiologically relevant model.
The Impact of Nutrition on T Cell Fate and Exhaustion
Researchers at the Salk Institute have discovered that a switch from acetate to citrate as a nutritional source significantly influences T cell identity, particularly transforming active effector T cells into exhausted ones in chronic infections like cancer and HIV.
The Complexities and Risks of Microbiome Interventions for Children
Probiotics, touted for their health benefits, are raising FDA safety warnings and concerns about their use in infants, while regulatory challenges similarly impact fecal microbiota transplants (FMT). Consequently, medical professionals urge caution with probiotics and FMT in vulnerable groups, emphasizing potential risks over benefits.
Tick Tock: The Growing Risk of Lyme Disease and Efforts to Develop a Vaccine
In this blog we discuss Lyme disease, including reasons for increased prevalence, causes and symptoms, and vaccine developments.
An Introduction to Infectious Disease Modeling
Hear ICON experts give an in-depth overview of infectious disease modeling with a focus on assessment of interventions and its challenges.
International COVID-19 Network at Work Virtual Panel – Part 2
Join prominent members of the International COVID-19 Network for a 2-part virtual panel where they will present the advantage of exchanging data and their results along detection, outcome prediction and Long-COVID risks and monitoring.
International COVID-19 Network at Work Virtual Panel – Part 1
Join prominent members of the International COVID-19 Network for a 2-part virtual panel where they will present the advantage of exchanging data and their results along detection, outcome prediction and Long-COVID risks and monitoring.
